bims-emyelo Biomed News
on Emergency myelopoiesis
Issue of 2026–11–08
four papers selected by
Robbin Kramer, Radboudumc



  1. Front Immunol. 2026 ;17 1760577
      Abnormalities in bone marrow microenvironment (BMM) represent a key mechanism closely related to the occurrence and progression of autoimmune diseases (AIDs). They involve dysfunction of critical microenvironment components: reduced supportive function of mesenchymal stromal cells (MSCs) leads to decreased secretion of the anchoring factor CXCL12, disrupting the quiescent state of hematopoietic stem cells (HSCs); dysregulation of sympathetic tone disturbs the circadian rhythm of hematopoietic cell arrangement; and abnormal proliferation of adipocytes fosters a pro-inflammatory environment. Collectively, these changes are related to a functional shift in the microenvironment from homeostasis maintenance to inflammation promotion, directionally biasing HSCs towards differentiation into pro-inflammatory immune lineages and facilitating massive release into the periphery. It establishes a pathogenic vicious cycle: peripheral autoimmune inflammation feeds back to the bone marrow (BM), further remodeling the microenvironment and perpetuating the production of aggressive immune cells, including autoreactive T cells, autoantibody-producing cells, and pro-inflammatory myeloid cells. As a result, patients experience a persistent inflammatory state that resists complete resolution, and disease progression is characterized by systemic involvement, chronicity, and relapsing course. This review focuses on the cellular and molecular components, functional roles, pathological alterations, and mechanisms of the BMM in AIDs. The review aims to provide an essential foundation for further investigation into the pathogenesis of autoimmune diseases.
    Keywords:  autoimmune diseases; bone marrow microenvironment; hematopoietic stem cells; immunomodulation; mesenchymal stromal cells
    DOI:  https://doi.org/10.3389/fimmu.2026.1760577
  2. J Leukoc Biol. 2026 Nov 06. pii: qiag141. [Epub ahead of print]
      The prevalence of obesity among adults of childbearing age has tripled worldwide since 1975. Obesity during pregnancy has been linked to impaired neonatal immunity and a higher risk of infections in childhood but the causal mechanisms have not been defined. Using a mouse model of diet-induced obesity, we documented impaired antiviral immunity in the offspring of obese mice, corresponding with reduced cell-mediated immune responses. This included lower frequencies of Tbet+ CD4+ T helper 1 cells and a decrease in cytotoxic CD8+ T cells in the lungs of mice infected with respiratory Sendai virus, and confirmed in spleens from mice infected with LCMV. Consistent with impaired cellular immunity, single-cell transcriptomic analysis of bone marrow revealed altered hematopoiesis in these offspring, with evidence of interferon-induced skewing toward myelopoiesis at the expense of lymphocyte development. Our studies provide an in-depth transcriptomic profile of immune cell progenitors in the bone marrow paired with mature innate and adaptive immune cell populations in lymph nodes at single-cell resolution. Results suggest that compromised immune protection from viral infections in the offspring of obese mice stems from altered lymphocyte development that is influenced by inflammatory interferon signaling in bone marrow.
    Keywords:  Obesity; hematopoiesis; immunity; neonatology; viral infection
    DOI:  https://doi.org/10.1093/jleuko/qiag141
  3. Front Immunol. 2026 ;17 1987932
      The gut microbiota, as a complex ecological system within the host, plays a critical role not only in regulating local intestinal immunity and metabolism but also in influencing hematopoietic stem cell (HSC) function and immune cell lineage differentiation through the gut-bone marrow axis. This review comprehensively examines how the gut microbiota remodels hematopoiesis and immune status via multiple mechanisms, particularly by modulating systemic inflammation, the bone marrow microenvironment, and HSC fate decisions. Special emphasis is placed on the role of Toll-like receptor (TLR) signaling pathways in linking the gut microbiota to bone metabolism and immune regulation. The review also integrates recent insights from single-cell sequencing technologies that reveal hematopoietic lineage biases in the bone marrow and explores the development and immune memory of gut-associated B cell populations during early life. By systematically synthesizing recent advances in the interaction between gut microbiota and bone marrow hematopoiesis, this article aims to provide a theoretical foundation for understanding how gut microbiota regulate systemic immune homeostasis and bone metabolism and to identify potential therapeutic targets for future interventions.
    Keywords:  bone marrow axis; bone metabolism; gut microbiota; hematopoietic stem cells; immune regulation; systemic inflammation; toll-like receptors
    DOI:  https://doi.org/10.3389/fimmu.2026.1987932
  4. Virulence. 2026 Dec;17(1): 2730393
      Bloodstream infections (BSI) caused by Escherichia coli and Staphylococcus aureus are frequent and are associated with substantial mortality rate. The host immune response major determinant of the clinical outcomes during BSI. Here, we investigated the innate immune response, by characterizing peripheral blood myeloid cell subsets and caspase-1 activation as a surrogate marker of inflammasome activation in patients with E. coli or S. aureus bacteremia. We prospectively enrolled patients with monomicrobial bacteremia and analyzed peripheral blood samples by flow cytometry. We observed distinct alterations in myeloid cell composition and caspase-1 activation associated with E. coli bacteremia, including an expansion in intermediate and non-classical monocytes, and increased caspase-1 activation in non-classical monocytes. In contrast, these changes were not observed in patients with S. aureus bacteremia. Additionally, we found differences in myeloid cell subset frequencies and caspase-1 activation between patients with and without sepsis, revealing distinct profiles associated with disease severity. Importantly, the differences in myeloid cell subsets and caspase-1 activation between E. coli and S. aureus bacteremia were primarily attributable to the infecting bacteria rather than disease severity. Furthermore, our findings suggest that eosinophil counts, and caspase-1 activation may serve as potential markers to distinguish between bacterial BSI and viral infections. Overall, our study highlights the importance of considering both the infecting pathogen and disease severity when studying the host immune response during bacteremia and suggests that potential innate immune biomarkers may improve the diagnosis and clinical management of BSI.
    Keywords:  Bacteremia; E. coli; S. aureus; caspase 1; intermediate monocytes; non-classical monocytes
    DOI:  https://doi.org/10.1080/21505594.2026.2730393